These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9020998

  • 1. Preservation of hypothalamic-pituitary-adrenal axis fast-feedback responses in depression.
    Cooney JM, Dinan TG.
    Acta Psychiatr Scand; 1996 Dec; 94(6):449-53. PubMed ID: 9020998
    [Abstract] [Full Text] [Related]

  • 2. Intermediate glucocorticoid feedback of corticotropin secretion in patients with major depression.
    Kellner M, Holsboer F, Heuser I.
    Psychiatry Res; 1995 Nov 29; 59(1-2):157-60. PubMed ID: 8771231
    [Abstract] [Full Text] [Related]

  • 3. Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function.
    Rubin RT, Phillips JJ, McCracken JT, Sadow TF.
    Biol Psychiatry; 1996 Jul 15; 40(2):89-97. PubMed ID: 8793041
    [Abstract] [Full Text] [Related]

  • 4. Cortisol feedback during the HPA quiescent period in patients with major depression.
    Posener JA, DeBattista C, Williams GH, Schatzberg AF.
    Am J Psychiatry; 2001 Dec 15; 158(12):2083-5. PubMed ID: 11729034
    [Abstract] [Full Text] [Related]

  • 5. Rate-sensitive inhibition of ACTH release in depression.
    Carr DB, Wool C, Lydiard RB, Fisher J, Gelenberg A, Klerman G.
    Am J Psychiatry; 1984 Apr 15; 141(4):590-2. PubMed ID: 6322599
    [Abstract] [Full Text] [Related]

  • 6. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY, Lowy MT, Koenig JI.
    Adv Biochem Psychopharmacol; 1987 Apr 15; 43():165-82. PubMed ID: 3035885
    [No Abstract] [Full Text] [Related]

  • 7. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug 15; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 8. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression.
    O'Toole SM, Sekula LK, Rubin RT.
    Biol Psychiatry; 1997 Jul 15; 42(2):85-9. PubMed ID: 9209724
    [Abstract] [Full Text] [Related]

  • 9. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec 15; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 10. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP, Haskett RF, Albala AA, Carroll BJ, Lohr NE.
    Arch Gen Psychiatry; 1985 Apr 15; 42(4):383-6. PubMed ID: 3977556
    [Abstract] [Full Text] [Related]

  • 11. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA, Akil H, Haskett RF, Watson SJ.
    Biol Psychiatry; 1995 Mar 15; 37(6):355-63. PubMed ID: 7772643
    [Abstract] [Full Text] [Related]

  • 12. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
    Psychoneuroendocrinology; 2016 Jan 15; 63():247-53. PubMed ID: 26519779
    [Abstract] [Full Text] [Related]

  • 13. HPA axis function and temperament in depression: a negative report.
    Roy A.
    Biol Psychiatry; 1996 Mar 01; 39(5):364-6. PubMed ID: 8704068
    [Abstract] [Full Text] [Related]

  • 14. Response to oCRH in depressed and nondepressed adolescents: does gender make a difference?
    Dorn LD, Burgess ES, Susman EJ, von Eye A, DeBellis MD, Gold PW, Chrousos GP.
    J Am Acad Child Adolesc Psychiatry; 1996 Jun 01; 35(6):764-73. PubMed ID: 8682757
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.
    Roy M, Collier B, Roy A.
    Psychiatry Res; 1990 Jan 01; 31(1):31-7. PubMed ID: 2156275
    [Abstract] [Full Text] [Related]

  • 16. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder.
    Yehuda R, Levengood RA, Schmeidler J, Wilson S, Guo LS, Gerber D.
    Psychoneuroendocrinology; 1996 Jan 01; 21(1):1-16. PubMed ID: 8778898
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder.
    Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW.
    Biol Psychiatry; 1991 Nov 15; 30(10):1031-48. PubMed ID: 1661614
    [Abstract] [Full Text] [Related]

  • 18. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.
    Jehn CF, Kühnhardt D, Bartholomae A, Pfeiffer S, Schmid P, Possinger K, Flath BC, Lüftner D.
    Integr Cancer Ther; 2010 Sep 15; 9(3):270-5. PubMed ID: 20702499
    [Abstract] [Full Text] [Related]

  • 19. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
    Ryan MC, Sharifi N, Condren R, Thakore JH.
    Psychoneuroendocrinology; 2004 Sep 15; 29(8):1065-70. PubMed ID: 15219658
    [Abstract] [Full Text] [Related]

  • 20. Cortisol response to vasopressin in depression.
    Krahn DD, Meller WH, Shafer RB, Morley JE.
    Biol Psychiatry; 1985 Aug 15; 20(8):918-21. PubMed ID: 2992617
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.